1GENE

1GENE (壹基因) is the brand of Hangzhou He-Yi Gene Technology Co., Ltd., a Chinese molecular-diagnostics company founded in Hangzhou's Binjiang district in May 2014 by chairman and chief executive Junyi Wang. It develops non-invasive early cancer screening tests built on proprietary tumour DNA methylation markers and liquid- and stool-based biopsy chemistry, sold under the mission of "letting everyone stay away from cancer earlier". Its product pipeline covers colorectal cancer screening (常壹宁), gastric pathogen screening and medication guidance (优壹宁), gastric cancer screening (卫壹宁), and liver and oesophageal cancer screening in development; company scientists co-authored a validated stool-DNA biomarker panel for colorectal neoplasms in the Journal of Cancer Research and Clinical Oncology. The company raised an angel round in 2014, a RMB 49.5M Series A in 2015 and a Series B of several tens of millions of RMB from listed pharmaceutical maker Chengda Pharmaceuticals in December 2022, and its shares are listed for secondary-market trading on EquityZen. 1GENE sells a clinical test, not software: it publishes no developer program, no public API, no SDK and no machine-readable specification, and as of this profile its own web origin at www.1gene.com.cn is unconfigured and serves a placeholder page.

1GENE is profiled on the APIs.io network. Tagged areas include Company, Health, Healthcare, Biotechnology, and Genomics.

3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-09-25 · rubric v0.23.0
0 APIs
CompanyHealthHealthcareBiotechnologyGenomicsDiagnosticsCancer ScreeningPrecision MedicineLife SciencesChina

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-25 · rubric v0.23.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/1gene: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

1Gene Domain Security

no transport/DNS hardening detected

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Source (apis.yml)

apis.yml Raw ↑
aid: 1gene
name: 1GENE
description: '1GENE (壹基因) is the brand of Hangzhou He-Yi Gene Technology Co., Ltd., a Chinese molecular-diagnostics company
  founded in Hangzhou''s Binjiang district in May 2014 by chairman and chief executive Junyi Wang. It develops non-invasive
  early cancer screening tests built on proprietary tumour DNA methylation markers and liquid- and stool-based biopsy chemistry,
  sold under the mission of "letting everyone stay away from cancer earlier". Its product pipeline covers colorectal cancer
  screening (常壹宁), gastric pathogen screening and medication guidance (优壹宁), gastric cancer screening (卫壹宁), and liver and
  oesophageal cancer screening in development; company scientists co-authored a validated stool-DNA biomarker panel for colorectal
  neoplasms in the Journal of Cancer Research and Clinical Oncology. The company raised an angel round in 2014, a RMB 49.5M
  Series A in 2015 and a Series B of several tens of millions of RMB from listed pharmaceutical maker Chengda Pharmaceuticals
  in December 2022, and its shares are listed for secondary-market trading on EquityZen. 1GENE sells a clinical test, not
  software: it publishes no developer program, no public API, no SDK and no machine-readable specification, and as of this
  profile its own web origin at www.1gene.com.cn is unconfigured and serves a placeholder page.'
url: https://raw.githubusercontent.com/api-evangelist/1gene/refs/heads/main/apis.yml
x-harvest-source-url: https://equityzen.com/company/1gene
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: no-api-surface
x-legal-name: 杭州和壹基因科技有限公司 (Hangzhou He-Yi Gene Technology Co., Ltd.)
x-founded: 2014-05
x-headquarters: Binjiang District, Hangzhou, Zhejiang, China
x-domain-status: origin-not-configured
x-domain-note: 'The company''s registrable domain 1gene.com.cn is still registered through Alibaba Cloud (created 2014-04-06,
  expires 2027-04-06, status ok) and still carries live NetEase MX and SPF records, so the domain is held by the company group.
  The web origin behind it is not configured: www.1gene.com.cn answers HTTP 200 with the stock Nginx Proxy Manager "Default
  Site" placeholder (Last-Modified 2026-06-03), HTTPS on that host aborts the TLS handshake with unrecognized_name, and the
  apex plus the m./admin. subdomains do not answer at all. Every /.well-known/ and contract-discovery path on the reachable
  host returns a real 404. Because a placeholder is not a web presence, no type Website pointer is wired — the same posture
  applied to other harvest records with dead origins (roadmap#56). The EquityZen page that surfaced this company is a trading
  venue and is recorded as x-harvest-source-url, never as a Website. See well-known/1gene-well-known.yml for the full probe
  record.'
deliveryModel:
  model: unknown
  open_source: false
  commercial: true
  callable_host: false
  label: Clinical diagnostics service — no callable API surface on record
  confidence: medium
  source:
  - well-known/1gene-well-known.yml
  generated: '2026-09-05'
  method: derived
specificationVersion: '0.23'
created: '2026-09-05'
modified: '2026-09-05'
tags:
- Company
- Health
- Healthcare
- Biotechnology
- Genomics
- Diagnostics
- Cancer Screening
- Precision Medicine
- Life Sciences
- China
tags_raw:
- Company
- Health
- Healthcare
- Biotechnology
- Genomics
- Diagnostics
- Cancer Screening
- Precision Medicine
- Life Sciences
- China
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/1gene-domain-security.yml
x-coverage:
  state: none
  reason: no-developer-program
  detail: 1GENE sells non-invasive cancer early-screening lab tests to consumers and clinics and publishes no developer program
    in either Chinese- or English-language sources; its own www.1gene.com.cn now answers HTTP 200 with an unconfigured Nginx
    Proxy Manager "Default Site" placeholder and every /.well-known/ and spec path on it returns a real 404, with no api./open./developer./docs.
    subdomain resolving and no GitHub organization or published package anywhere.
  evidence:
  - url: http://www.1gene.com.cn/
    status: 200
  - url: http://www.1gene.com.cn/openapi.json
    status: 404
  - url: http://www.1gene.com.cn/.well-known/agent-card.json
    status: 404
  - url: http://www.1gene.com.cn/llms.txt
    status: 404
  - url: https://api.github.com/orgs/1gene
    status: 404
  - url: https://pypi.org/pypi/1gene/json
    status: 404
  checked: '2026-09-05'
x-enrichment:
  date: '2026-09-05'
  status: minimal
  artifacts_added: 2
  pass: local-v3

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/1gene"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/1gene/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/1gene/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.